363 related articles for article (PubMed ID: 30620802)
1. [Uremic toxins and gut micro biome].
Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
[TBL] [Abstract][Full Text] [Related]
2. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
Vaziri ND; Zhao YY; Pahl MV
Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
[TBL] [Abstract][Full Text] [Related]
3. The Chronic Kidney Disease - Colonic Axis.
Pahl MV; Vaziri ND
Semin Dial; 2015; 28(5):459-63. PubMed ID: 25855516
[TBL] [Abstract][Full Text] [Related]
4. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
Vaziri ND
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):587-92. PubMed ID: 23010760
[TBL] [Abstract][Full Text] [Related]
5. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
Lau WL; Vaziri ND
J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
[TBL] [Abstract][Full Text] [Related]
6. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
7. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
8. The gut-kidney axis.
Evenepoel P; Poesen R; Meijers B
Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
10. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome in chronic kidney disease.
Wing MR; Patel SS; Ramezani A; Raj DS
Exp Physiol; 2016 Apr; 101(4):471-7. PubMed ID: 26337794
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome, kidney disease, and targeted interventions.
Ramezani A; Raj DS
J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
[TBL] [Abstract][Full Text] [Related]
15. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
Yang CY; Tarng DC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and the gut microbiome.
Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
[TBL] [Abstract][Full Text] [Related]
19. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
20. The impact of gut microbiota on kidney function and pathogenesis.
Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]